Please find the session links next to their corresponding agenda item.

Tuesday, October 11

12:00 PM 

Welcome and Course Overview
Khara L. Minter, Assistant Director, Training Programs, FDLI

Enter this session:

12:15–1:30 PM 

I. Applicable FDA Offices, Essential Principles, & Key Definitions
Stephanie Jameison
, Sr. Director, Global Regulatory Affairs, Promotion Compliance, Otsuka America Pharmaceutical, Inc.

Enter this session:

1:45–2:00 PM 


2:00–3:00 PM 

II. Dissemination of Non-Promotional Information
Gillian M. Russell, Counsel, King & Spalding LLP

Enter this session:

3:00 – 3:15 PM


3:15–4:00 PM

III. Other Agencies and Considerations
Heather Banuelos, Counsel, King & Spalding LLP
Enter this session:

4:00–4:15 PM


4:15–5:15 PM

IV. Case Studies/Hypotheticals
Erin Carducci, Director, Regulatory Advertising & Promotion, Digital Strategy & Innovation, Novartis Pharmaceuticals Corporation
John Kung, Deputy Head of Legal, Customer Strategy & Engagement, Novartis Pharmaceuticals Corporation

Enter this session:

5:15 PM

Course Adjournment

CLE Information


This event is pending approval in Ohio. To obtain credit, please email [email protected] at the end of the conference and include your state bar number along with how many credits you wish to obtain. FDLI will certify your attendance for you. An evaluation is required to obtain credit.


This event is pending approval in Virginia. Please email [email protected] to request a Virginia form. You will need to certify your attendance online at Retain the Certificate of Attendance for two years.

Other States

These CLE approvals may also be honored by other states; please check with your bar association for guidance. At the end of the conference, please email [email protected] to receive a certificate of attendance.